Skip to main content
Have a personal or library account? Click to login
Targeted Delivery of Shear Stress-Inducible microRNAs by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions Cover

Targeted Delivery of Shear Stress-Inducible microRNAs by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions

Open Access
|Jul 2016

References

  1. Libby P , Ridker PM , Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5; 105( 9): 113543.
  2. Beckman JA , Creager MA , Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002 May 15; 287( 19): 257081.
  3. Packard RR Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008 Jan; 54( 1): 2438.
  4. Casscells W , Naghavi M , Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 2003 Apr 29; 107( 16): 20725.
  5. Libby P , Ridker PM , Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011 May 19; 473( 7347): 31725.
  6. Libby P , Ridker PM , Hansson GK ; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009 Dec 1; 54( 23): 212938.
  7. Jaipersad AS , Lip GY , Silverman S , Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014 Jan 7–14; 63( 1): 111.
  8. Zernecke A Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014 Apr; 34( 4): 74250.
  9. Shah PK. Inflammation and plaque vulnerability. Cardiovasc Drugs Ther. 2009 Feb; 23( 1): 3140.
  10. Camici PG , Rimoldi OE , Gaemperli O , Libby P. Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J. 2012 Jun; 33( 11): 130917.
  11. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013 May 23; 368( 21): 200413.
  12. Chiu JJ Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011 Jan; 91( 1): 32787.
  13. Moore KJ , Sheedy FJ , Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013 Oct; 13( 10): 70921.
  14. Flammer AJ , Anderson T , Celermajer DS , The assessment of endothelial function: from research into clinical practice. Circulation. 2012 Aug 7; 126( 6): 75367.
  15. Libby P , Lichtman AH , Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013 Jun 27; 38( 6): 1092104.
  16. Yoon MH , Reriani M , Mario G , Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol. 2013 Sep 30; 168( 2): 131621.
  17. Schmitt MM , Megens RT , Zernecke A , Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014 Jan 7; 129( 1): 6676.
  18. Funk SD , Yurdagul A Jr , Albert P , EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 Mar; 32( 3): 68695.
  19. van Gils JM , Ramkhelawon B , Fernandes L , Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler Thromb Vasc Biol. 2013 May; 33( 5): 9119.
  20. Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol Heart Circ Physiol. 2007 Mar; 292( 3): H120924.
  21. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995 Jul; 75( 3): 51960.
  22. Li YS , Haga JH , Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech. 2005 Oct; 38( 10): 194971.
  23. Kilner PJ , Yang GZ , Mohiaddin RH , Firmin DN , Longmore DB. Helical and retrograde secondary flow patterns in the aortic arch studied by three-directional magnetic resonance velocity mapping. Circulation. 1993 Nov; 88( 5 Pt 1): 223547.
  24. Libby P Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 Jun 28; 111( 25): 34818.
  25. Stone PH , Coskun AU , Yeghiazarians Y , Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol. 2003 Nov; 18( 6): 45870.
  26. VanderLaan PA , Reardon CA , Getz GS. Site specificity of atherosclerosis: Site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004 Jan; 24( 1): 1222.
  27. Asakura T Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990 Apr 1; 66: 104566
  28. Hsiai TK , Cho SK , Wong PK , Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J. 2003 Sep; 17( 12): 164857.
  29. Shyy YJ , Hsieh HJ , Usami S , Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci U S A. 1994 May 24; 91( 11): 467882.
  30. Hwang J , Ing MH , Salazar A , Lassègue B , Griendling K , Navab M , Sevanian A , Hsiai TK. Pulsatile versus oscillatory shear stress regulates nadph oxidase subunit expression: Implication for native ldl oxidation. Circ Res. 2003 Dec 12; 93( 12): 122532.
  31. Malek AM , Gibbons GH , Dzau VJ , Izumo S. Fluid shear stress differentially modulates expression of genes encoding basic fibro-blast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest. 1993 Oct; 92( 4): 201321.
  32. Traub O Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998 May; 18( 5): 67785.
  33. Berk BC. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells. Circulation. 2008 Feb 26; 117( 8): 10829.
  34. Schober A , Nazari-Jahantigh M , Wei Y , MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014 Apr; 20( 4): 36876.
  35. Son DJ , Kumar S , Takabe W , The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat Commun. 2013; 4: 3000.
  36. Hergenreider E , Heydt S , Tréguer K , Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012 Feb 12; 14( 3): 24956.
  37. Zhou J , Wang KC , Wu W , MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci U S A. 2011 Jun 21; 108( 25): 1035560.
  38. Ni CW , Qiu H , Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol. 2011 May; 300( 5): H17629.
  39. Qin X , Wang X , Wang Y , MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A. 2010 Feb 16; 107( 7): 32404.
  40. Loyer X , Potteaux S , Vion AC , Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res. 2014 Jan 31; 114( 3): 43443.
  41. Blanco E , Shen H , Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015 Sep; 33( 9): 94151.
  42. Ferrari M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol. 2010 Apr; 28( 4): 1818.
  43. Shen H , Mittal V , Ferrari M , Chang J. Delivery of gene silencing agents for breast cancer therapy. Breast Cancer Res. 2013 May 8; 15( 3): 205.
  44. Shen H , Sun T , Ferrari M. Nanovector delivery of siRNA for cancer therapy. Cancer Gene Ther. 2012 Jun; 19( 6): 36773.
  45. Tasciotti E , Liu X , Bhavane R , Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol. 2008 Mar; 3( 3): 1517.
  46. Shen H , Rodriguez-Aguayo C , Xu R , Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res. 2013 Apr 1; 19( 7): 180615.
  47. Xu R , Huang Y , Mai J , Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small. 2013 May 27; 9( 9–10): 1799808.
  48. Dave B , Granados-Principal S , Zhu R , Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proc Natl Acad Sci U S A. 2014 Jun 17; 111( 24): 883843.
  49. Mai J , Huang Y , Mu C , Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. J Control Release. 2014 Aug 10; 187: 229.
  50. Zong H , Sen S , Zhang G , In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche. Leukemia. 2015 Dec 16.
  51. Ma S , Tian XY , Zhang Y , E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. Sci Rep. 2016 Mar 9; 6: 22910.
Language: English
Page range: 152 - 156
Published on: Jul 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2016 Wing Tak Wong, Shuangtao Ma, Xiao Yu Tian, Andrea Banuet Gonzalez, Eno E. Ebong, Haifa Shen, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.